Latest news
Schizophrenia’s Missing Symptoms Move Onto the Phone
A Phase III randomised trial found that a smartphone therapeutic improved motivation and pleasure-related negative symptoms of schizophrenia. The significance is not that an app replaces psychiatry. It is that psychiatry may finally be treating what medication often leaves behind.
GIST Care Looks Beyond First-Generation KIT Control
Pancreatic Cancer Finally Gets a RAS Moment
A Rare Pain Disorder Gets a Pivotal Trial
Soft-Cheese Listeria Outbreak Shows Food Safety Is Patient Safety
World Cup Health Guidance Turns Football Into a Public-Health Test
Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
What happens when surgeons no longer need to be in the same country as their patients?
EMA backs first oral obesity GLP-1 as pills push treatment towards mass-market adoption
As GLP-1 use expands, healthcare systems are confronting a new challenge: balancing obesity treatment with rising concerns about eating disorders and patient safety.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.